Emergence and antigenic characterisation of influenza A(H3N2) viruses with hemagglutinin substitutions N158K and K189R during the 2024/25 influenza season.

Saved in:
Bibliographic Details
Title: Emergence and antigenic characterisation of influenza A(H3N2) viruses with hemagglutinin substitutions N158K and K189R during the 2024/25 influenza season.
Authors: Koel B; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands., Byrne AM; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom., Turner S; Center for Pathogen Evolution, University of Cambridge, Cambridge, United Kingdom., James S; Center for Pathogen Evolution, University of Cambridge, Cambridge, United Kingdom., Harvey R; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom., Galiano M; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom., Carr C; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom., Lexmond P; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands., Pronk M; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands., Liang R; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Boons GJ; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; Complex Carbohydrate Research Center, Department of Chemistry, Athens, USA.; Center for Influenza Disease and Emergence Response, University of Georgia, Athens, USA.; Department of Chemistry, University of Georgia, Athens, USA., de Vries RP; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Eggink D; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Lewis N; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom., Smith D; Center for Pathogen Evolution, University of Cambridge, Cambridge, United Kingdom., Meijer A; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Fouchier R; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 Feb 10. Date of Electronic Publication: 2026 Feb 10.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.64898/2026.02.10.704996